Asker Healthcare Group AB (ASKER) Stock Statistics & Valuation Metrics

Asker Healthcare Group AB has a market cap or net worth of kr38.29B. The enterprise value is kr45.15B.

Asker Healthcare Group AB has 383,036,500 shares outstanding. The number of shares has decreased by -2.65% in one year.

Asker Healthcare Group AB’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is 6.17%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Asker Healthcare Group AB had revenue of 15.03B and earned 360.00M in profits. Earnings per share was 0.94.

In the last 12 months, operating cash flow was 109.00M and capital expenditures -72.00M, giving a free cash flow of 37.00M billion.

Asker Healthcare Group AB pays an annual dividend of ―, resulting in a dividend yield of ―

Asker Healthcare Group AB upcoming earnings date is Nov 6, 2025, Before Open (Confirmed).

Asker Healthcare Group AB as a current ratio of 1.40, with Debt / Equity ratio of 68.32%

In the past 12 months, Asker Healthcare Group AB has paid 183.00M in taxes.

Asker Healthcare Group AB EV to EBITDA ratio is 25.55, with an EV/FCF ratio of 42.69.

Asker Healthcare Group AB has kr735.00M in cash and marketable securities with kr4.24B in debt, giving a net cash position of kr3.50B billion.

Gross margin is 39.81%, with operating margin of 6.43%, and net profit margin of 2.40%.

The average price target for Asker Healthcare Group AB is kr100.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy